JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 8 March 2006. doi:10.1136/jcp.2005.032730
Journal of Clinical Pathology 2006;59:958-964
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2005.032730v1
59/9/958    most recent
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H
Right arrow Articles by Li, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H
Right arrow Articles by Li, E

ORIGINAL ARTICLE

Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma

H Zhang1,*, L Xu2,3,*, D Xiao4, J Xie1, H Zeng1, W Cai3, Y Niu1, Z Yang1, Z Shen3, E Li1

1 Department of Biochemistry and Molecular Biology, Medical College of Shantou University, Shantou, Guangdong Province, PR China
2 Institute of Virology and Pharmacology, College of Life Science and Bioengineering, Beijing University of Technology, Beijing, PR China
3 Department of Pathology, Medical College of Shantou University
4 Department of Cardiothoracic Surgery, First Affiliated Hospital of Shantou University, Shantou

Correspondence to:
E Li
Department of Biochemistry and Molecular Biology, Medical College of Shantou University, 22 Xinling Road, Shantou City, Guangdong Province, PR China;nmli{at}stu.edu.cn Background: Fascin, an actin-binding protein, is usually expressed at a low level in normal epithelium, but is markedly up regulated in several types of carcinomas. Reports on fascin expression in oesophageal squamous cell carcinoma (ESCC) and precancerous lesions remain rare.

Aim: To show the roles of fascin in the progression from normal epithelium to invasive ESCC.

Methods: Fascin expression in 102 sections embedded in paraffin wax, including samples of normal mucosa (n = 20), dysplasia (n = 10), ESCC (n = 62) and special sections (n = 10) of a full-length mucosa layer from the distant margin to the cancer focus of the excised oesophagus, and 49 fresh specimens of ESCC was analysed by immunohistochemistry, western blot and real-time reverse transcription-polymerase chain reaction. Fascin expression in ESCC cell lines was also investigated.

Results: In the immunohistochemical study, the positive rate of fascin was significantly higher in the tumour tissue than in the normal epithelium (p = 0.020), but no significant difference was shown between ESCC and dysplasia (p = 1.000). Immunostaining for fascin was only apparent in the basal layer of the normal epithelium. However, in the dysplasia, positive staining was observed in most of the heterogeneous cells from the basal layer to the granular layer of the epithelium. Fascin expression was seen to increase progressively from the normal epithelium to invasive ESCC. Up regulation of fascin was observed in 87.76% (43/49) and 77.55% (38/49) of the specimens, respectively, using western blot and real-time reverse transcription-polymerase chain reaction assays; 80% (4/5) of ESCC cell lines also expressed fascin at a high level. Furthermore, overexpression of fascin was markedly correlated with cell proliferation and lymph node metastasis.

Conclusions: These findings suggested that fascin was associated with the transformation and development of ESCC and implicated the potential of fascin as a novel biomarker that would allow the tumour to be identified at an early stage in high-risk individuals.


Abbreviations: ESCC, oesophageal squamous cell carcinoma; IgG, immunoglobulin G; RT-PCR, reverse transcription-polymerase chain reaction; PBS, phosphate-buffered saline; PCNA, proliferating cell nuclear antigen




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
F.-R. Zhang, L.-H. Tao, Z.-Y. Shen, Z. Lv, L.-Y. Xu, and E.-M. Li
Fascin Expression in Human Embryonic, Fetal, and Normal Adult Tissue
J. Histochem. Cytochem., February 1, 2008; 56(2): 193 - 199.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Re: Zhang H, Xu L, Xiao D et al. Fascin is a potential biomarker for early-stage
Olorunda Rotimi
JCP Online, 9 Oct 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.